Investment Analysts’ New Coverage for May 15th (BIIB, BIO, CCNE, CLRB, DVN, EBC, EL, ORRF, RNA, SJM)

Investment Analysts’ new coverage for Friday, May 15th:

Evercore Inc started coverage on shares of Biogen (NASDAQ:BIIB). Evercore Inc issued an outperform rating on the stock.

Royal Bank Of Canada started coverage on shares of Bio-Rad Laboratories (NYSE:BIO). They issued an outperform rating and a $320.00 target price on the stock.

DA Davidson assumed coverage on shares of CNB Financial (NASDAQ:CCNE). The firm issued a neutral rating and a $34.00 target price on the stock.

LADENBURG THALM/SH SH assumed coverage on shares of Cellectar Biosciences (NASDAQ:CLRB). The firm issued a buy rating on the stock.

Evercore Inc began coverage on shares of Devon Energy (NYSE:DVN). They issued an in-line rating and a $54.00 target price on the stock.

DA Davidson initiated coverage on shares of Eastern Bankshares (NASDAQ:EBC). The firm issued a buy rating and a $24.00 target price on the stock.

Piper Sandler began coverage on shares of Estee Lauder Companies (NYSE:EL). Piper Sandler issued an overweight rating and a $95.00 price target on the stock.

DA Davidson started coverage on shares of Orrstown Financial Services (NASDAQ:ORRF). DA Davidson issued a neutral rating and a $41.00 price target on the stock.

Leerink Partners began coverage on shares of Avidity Biosciences (NASDAQ:RNA). Leerink Partners issued an outperform rating on the stock.

Evercore Inc began coverage on shares of J. M. Smucker (NYSE:SJM). They issued an outperform rating and a $117.00 target price on the stock.

Wedbush began coverage on shares of Solventum (NYSE:SOLV). Wedbush issued an outperform rating and a $94.00 target price on the stock.

DA Davidson began coverage on shares of Unity Bancorp (NASDAQ:UNTY). DA Davidson issued a buy rating and a $68.00 price target on the stock.